Quanticate
Quanticate is a privately held, global biometrics-focused Contract Research Organisation founded in 1994, serving pharmaceutical, biotechnology, and medical device companies with statistical programming, clinical data management, biostatistics, medical writing, and pharmacovigilance services across all clinical trial phases.
- Company typePrivate
- Founded1994
- HeadquartersRaleigh, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Quanticate does
Quanticate is a privately held, data-focused Contract Research Organisation (CRO) founded in 1994 and headquartered between Hitchin, UK and Raleigh, NC, USA, with 251-500 employees across offices in the UK, US, Canada, Poland, South Africa, and India. The firm operates exclusively in biometrics and clinical data services, offering six core service lines: Statistical Consultancy, Biostatistics, Statistical Programming, Clinical Data Management, Regulatory Medical Writing, and Pharmacovigilance. These are supported by specialist add-on modules including PK/PD analysis, Real World Evidence, ISS/ISE Submissions, Rescue Studies, CDISC Services & Mapping, Functional Service Provision (FSP), Centralised Data Solutions (CDS), Data Quality Oversight, Bayesian Methods in Clinical Design, and Clinical Trial Transparency.
The technology stack is built around the proprietary iQ Portal for centralized clinical and safety data storage, study-level metrics, and cross-study visualization, combined with SAS and R programming environments and CDISC SDTM/ADaM standards compliance. AI and automation tooling is layered on top of these capabilities to accelerate SAP creation, TLF production, and CSR generation, with the stated design intent of combining structured metadata and regulatory standards with human expert review. The firm also applies machine learning techniques to EDC data extracts for clinical data management and programming workflows.
Quanticate generates revenue through professional services contracts under three engagement models: Functional Service Provision (FSP) with multi-year embedded teams billed on an FTE basis, Fixed Cost Projects billed per-engagement, and Full Service CRO Support on multi-year hybrid contracts. The go-to-market is enterprise field sales targeting emerging biotechs, mid-to-large pharmaceutical and biotech companies, and medical device firms, supported by an RFI-driven sales process with two-business-day response SLAs and a content marketing program spanning whitepapers, case studies, videos, podcasts, and major social channels. Selected named customers include a Top 5 Pharmaceutical Company, a Large Global Pharma, a Large Scandinavian Pharmaceutical Company, a European Mid-Size Biotech, and a Fertility Biotech. The company is registered as Quanticate International Limited in England and Wales, with David Underwood serving as Founding CEO and Chairman.
Quanticate firmographics
Firmographics- Name
- Quanticate
- Legal name
- Quanticate International Limited
- Website
- https://quanticate.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Quanticate is a privately held, global biometrics-focused Contract Research Organisation founded in 1994, serving pharmaceutical, biotechnology, and medical device companies with statistical programming, clinical data management, biostatistics, medical writing, and pharmacovigilance services across all clinical trial phases.
- Ownership category
- akta.pro rank
Quanticate industry classification
Industry- Product category
- Clinical Research Services (Contract Research Organization)
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
- akta.pro secondary industries
- Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB), Medical Writing & Clinical Documentation FSP (HLAGAOAC), Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK)
Keywords
Where Quanticate is headquartered
LocationHeadquarters
- HQ city
- Raleigh
- HQ country
- United States
- HQ region
- North America
Offices8 records
Markets served
Quanticate business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract Research Services: Quanticate generates revenue through contract research services including biostatistics, statistical programming, clinical data management, medical writing, pharmacovigilance, and regulatory consulting. Services are delivered through Functional Service Provision (FSP) models, fixed-cost project engagements, and full-service CRO arrangements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Functional Service Provision (FSP) - embedded team model |
| One time/ perpetual license | Pay-as-you-go | Fixed Cost Projects - per-project engagement |
| Hybrid | Multi-year contract | Full Service CRO Support |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels9 records
Quanticate product offering
Product offeringCore offering
Quanticate is a data-focused Contract Research Organisation (CRO) providing biometrics and clinical data services to pharmaceutical, biotech, and medical device companies. Core offerings include statistical consultancy, biostatistics, statistical programming (SAS/R with CDISC SDTM/ADaM), clinical data management, regulatory medical writing, and pharmacovigilance, supported by specialist capabilities in PK/PD analysis, AI/automation, real-world evidence, rescue studies, ISS/ISE submissions, and Functional Service Provision (FSP) delivery models.
Product overview
Quanticate is a data-focused Contract Research Organisation (CRO) providing a unified biometrics and clinical data services platform spanning the full drug development lifecycle. With over 30 years of industry experience, its core offering is built around six principal services — Statistical Consultancy, Biostatistics, Statistical Programming, Clinical Data Management, Regulatory Medical Writing, and Pharmacovigilance — supported by specialist add-on modules including PK/PD Services, AI and Automation, Clinical Data Visualizations, Real World Evidence, ISS/ISE Submissions, Rescue Studies, CDISC Services, Functional Service Provision (FSP), Centralised Data Solutions (CDS), Data Quality Oversight, Bayesian Methods in Clinical Design, and Clinical Trial Transparency. The platform is powered by the proprietary iQ portal technology for centralized data storage, visualization, and study-level metrics. Clients include emerging biotechs, mid-large pharma and biotechs, and medical device companies.
Differentiator
Problem solved
Functional benefit
Products and services
- Statistical Consultancy Expert statistical input for protocol development, study design, sample size calculations, SAPs, TLF specifications, and mock-ups, including adaptive, Bayesian, and complex trial support for pharmaceutical and biotech sponsors.
- Biostatistics Statistical analysis and reporting services covering protocol statistical review, randomisation and unblinding, DSMBs support, CRF statistical review, SAP and output shells, and CSR review and production for clinical trials.
- Statistical Programming SAS and R programming turning validated clinical trial data into submission-ready datasets, tables, listings, and figures, including CDISC SDTM/ADaM development, TLF production, ISS/ISE data integration, and data anonymisation.
- Clinical Data Management End-to-end clinical trial data capture, cleaning, and locking services covering database build and EDC setup, CDASH-compliant CRF/eCRF design, medical coding, query management, external data reconciliation, RBQM, and DMP development.
- Regulatory Medical Writing Creation of accurate, evidence-based clinical and regulatory documents throughout the drug development lifecycle, including clinical study reports, protocols, CTD summaries, investigator brochures, patient safety narratives, and scientific communications.
- Pharmacovigilance Patient safety protection and compliance services across clinical trials and post-marketing products, covering case processing, expedited reporting, safety database hosting and migration, DSUR/PSUR/PBRER/PADER support, and QPPV, RMP, signal, and device vigilance services.
- Functional Service Provision (FSP) Flexible resourcing model providing scalable external functional biometric teams that can be flexibly adjusted to peaks and troughs in sponsor pipelines, including governance structures between sponsor and CRO for long-term embedded partnerships.
- Centralised Data Solutions (CDS) Data-focused clinical data outsourcing approach combining clinical data management, biostatistics, clinical programming, medical writing, and pharmacovigilance elements, utilizing centralized data storage and visualisation technology (iQ) for optimal clinical and safety data management.
- PK/PD Services Specialist pharmacokinetics (PK) and pharmacodynamics (PD) analysis using dedicated software and expertise to support dose optimization and regulatory submissions for investigational drugs.
- Real World Evidence Generation of insights from real-world data sources such as electronic medical records, claims data, and healthcare databases to support health economics, outcomes research (HEOR), and observational studies.
- ISS/ISE Submissions Pooling of safety and efficacy data across multiple studies for regulatory submission, including planning of analyses and summaries, data submission planning, report creation, and production-stage issue mitigation.
- Rescue Studies Expert support to resolve data, compliance, resource, and technology challenges in struggling clinical trials, protecting study integrity and setting research up for success.
- CDISC Services & Mapping CDISC standards expertise including SDTM and ADaM mapping, annotated CRF development, define.xml 2.0 preparation, and Pinnacle 21 validation for regulatory submissions.
- AI and Automation AI-driven tools that accelerate statistical documentation and clinical reporting by automating SAP creation, table output conversion, and CSR generation, combining structured metadata, regulatory standards, and human expert review for faster, traceable, and submission-ready outputs.
- Clinical Data Visualizations Free pre-database-lock Tables, Listings, and Figures visualisations offering early insights into potential trial reporting results, supporting real-time oversight and data review.
- Data Quality Oversight Risk-based quality management and data oversight services ensuring data integrity, regulatory compliance, and efficient monitoring across clinical trial conduct.
- Bayesian Methods in Clinical Design Adaptive and Bayesian trial design support enabling optimally designed studies that can reduce costs and save time through smaller sample sizes or earlier trial stopping without wasted efforts.
- Clinical Trial Transparency Clinical trial transparency services covering lay summaries, clinical trial registration and result disclosures, and data and document anonymisation to meet regulatory requirements and improve public access to trial information.
Quantifiable outcome
- Clean quality clinical trial databases delivered through established governance structures
- +3 more outcomes
Companies that use Quanticate
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Quanticate technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
Quanticate partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
Quanticate competitors and assessment
Company assessmentDirect peers
- Cytel: Cytel is a biostatistics and clinical data services CRO with deep expertise in statistical programming, adaptive trial design, and Bayesian methods, directly overlapping Quanticate's core biometrics offering for pharma and biotech sponsors.
- Statistics & Data Corporation (SDS): SDS is a biometrics-focused CRO offering biostatistics, statistical programming, and clinical data management to pharma and medical device sponsors, making it one of the most direct competitors to Quanticate's service portfolio.
- Rho: Rho is a contract research organization providing clinical data management, biostatistics, regulatory, and safety services to pharma and biotech, with comparable mid-market focus and biometrics-led service mix as Quanticate.
- Advanced Clinical: Advanced Clinical is a mid-size CRO offering clinical research, biometrics, and functional services to pharma and medical device sponsors, competing with Quanticate in data management and statistical programming.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO providing clinical development, biometrics, and pharmacovigilance services across all phases, with overlapping biostatistics and CDM offerings for pharma and biotech.
- Premier Research: Premier Research is a CRO serving biotech and specialty pharma with clinical development, biometrics, and medical writing services, comparable to Quanticate in mid-size segment targeting and biometrics specialization.
Broad incumbents
- ICON plc: ICON plc is a global full-service CRO with extensive biostatistics, programming, and data management capabilities. While much larger and broader than Quanticate, it competes for the same biometrics outsourcing budgets.
- IQVIA: IQVIA is the world's largest CRO with deep biometrics, real-world evidence, and technology capabilities. It competes with Quanticate at the high end of the biometrics outsourcing market while offering bundled full-service scale.
- Parexel International: Parexel is a global CRO with significant biometrics, biostatistics, and clinical data services capabilities, competing with Quanticate for biostatistics and programming engagements from mid-large pharma sponsors.
- Labcorp Drug Development: Labcorp Drug Development (formerly Covance) is a global CRO with substantial central laboratory, biometrics, and clinical development services, overlapping with Quanticate in CDM and biostatistics delivery for pharma sponsors.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Quanticate social profiles
Digital presenceQuanticate compliance and trust
Trust signalCompliance4 records
Quanticate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Quanticate leadership team
Management profileNumber of profiles
Profiles1 record
Quanticate funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Quanticate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Quanticate
What does Quanticate do?
Quanticate is a data-focused Contract Research Organisation (CRO) providing biometrics and clinical data services to pharmaceutical, biotech, and medical device companies. Core offerings include statistical consultancy, biostatistics, statistical programming (SAS/R with CDISC SDTM/ADaM), clinical data management, regulatory medical writing, and pharmacovigilance, supported by specialist capabilities in PK/PD analysis, AI/automation, real-world evidence, rescue studies, ISS/ISE submissions, and Functional Service Provision (FSP) delivery models.
Is Quanticate a public or private company?
Quanticate is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Quanticate founded?
Quanticate was founded in 1994. It employs 251 to 500 people.
Where is Quanticate based?
Quanticate is headquartered in Raleigh, United States, in the North America region.
How does Quanticate make money?
One revenue line is on record: contract Research Services.
Who are Quanticate's main competitors?
Direct peers on record are Cytel, Statistics & Data Corporation (SDS), Rho, Advanced Clinical, Worldwide Clinical Trials and Premier Research. Broad incumbents are ICON plc, IQVIA, Parexel International and Labcorp Drug Development.
Does Quanticate have an API?
No public API is recorded for Quanticate.
What industry is Quanticate in?
Quanticate's product category is Clinical Research Services (Contract Research Organization). Its primary akta.pro industry code is HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs, with a secondary code of HLAGAOAB, Data Management, Biostatistics & Statistical Programming FSP. Its NAICS code is 541714 and its SIC code is 8731.